IMC Chicago
ONC icon

IMC Chicago’s BeOne Medicines Ltd ONC Stock Holding History

IMC Chicago’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.83M Buy
5,000
+1,300
+35% +$445K ﹤0.01% 3242
2026
Q2 		$1.05M Sell
3,700
-5,000
-57% -$1.47M ﹤0.01% 3797
2026
Q1 		$2.58M Buy
+8,700
New +$2.82M ﹤0.01% 2330

Other funds holding ONC

Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Capital International Inc
Capital International Inc Los Angeles, California $13.9B AUM 25.98% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

IMC Chicago's ONC Position: Q3 2026 in Review

IMC Chicago sold out of BeOne Medicines Ltd (ONC) in Q3 2026, closing a stake of 1,949 shares — an estimated $666K sold.

IMC Chicago first reported a position in ONC in Q2 2026 and held it in 1 quarter. The position peaked at $555K in Q2 2026. 212 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • IMC Chicago reported no remaining BeOne Medicines Ltd position as of Q3 2026 after selling out during the quarter.
  • IMC Chicago sold 1,949 BeOne Medicines Ltd shares in Q3 2026, an estimated $666K.
  • IMC Chicago first reported a position in BeOne Medicines Ltd in Q2 2026 and held it in 1 quarter.
  • IMC Chicago's BeOne Medicines Ltd position peaked at $555K in Q2 2026.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.